Hepatic gene therapy: adenovirus enhancement of receptor-mediated gene delivery and expression in primary hepatocytes.
about
SKF-82958 is a subtype-selective estrogen receptor-alpha (ERalpha ) agonist that induces functional interactions between ERalpha and AP-1Stable polyplexes based on arginine-containing oligopeptides for in vivo gene delivery.Strategy of liver-directed gene therapy: present status and future prospects.Efficient gene transfer into human hepatocytes by baculovirus vectorsReceptor-mediated targeting of gene delivery vectors: insights from molecular mechanisms for improved vehicle design.Bone marrow extracellular matrix molecules improve gene transfer into human hematopoietic cells via retroviral vectors.In vivo gene therapy for hyperlipidemia: phenotypic correction in Watanabe rabbits by hepatic delivery of the rabbit LDL receptor gene.Long-term enzymatic and phenotypic correction in the phenylketonuria mouse model by adeno-associated virus vector-mediated gene transfer.Improved biological activity of antisense oligonucleotides conjugated to a fusogenic peptide.Non-viral gene transfer therapy for cystic fibrosis.State-of-the-art 2003 on PKU gene therapy.Gene therapy for vascular diseases.Parkin and relatives: the RBR family of ubiquitin ligases.Papillomavirus capsid binding and uptake by cells from different tissues and species.Enhanced resistance to nuclease degradation of nucleic acids complexed to asialoglycoprotein-polylysine carriers.Strategies to improve non-viral vectors--potential applications in clinical transplantation.Sequencing of PCR amplified HBV DNA pre-c and c regions in the 2.2.15 cells and antiviral action by targeted antisense oligonucleotide directed against sequenceHepatic gene therapy: efficient gene delivery and expression in primary hepatocytes utilizing a conjugated adenovirus-DNA complex.Protective effect of recombinant adeno-associated virus 2/8-mediated gene therapy from the maternal hyperphenylalaninemia in offsprings of a mouse model of phenylketonuria.Ex vivo gene delivery to hepatocytes: techniques, challenges, and underlying mechanisms.Target cell-specific DNA transfer mediated by a chimeric multidomain protein. Novel non-viral gene delivery system.Clinical therapeutics for phenylketonuria.Receptor mediated glycotargeting.Delivery of DNA into mammalian cells by receptor-mediated endocytosis and gene therapy.Increased sensitivity to the prodrug 5'-deoxy-5-fluorouridine and modulation of 5-fluoro-2'-deoxyuridine sensitivity in MCF-7 cells transfected with thymidine phosphorylase.Malarial circumsporozoite protein is a novel gene delivery vehicle to primary hepatocyte cultures and cultured cells.Gene therapy: Recent advances and applications in gastroenterology and hepatology.Enhancement of calcium phosphate-mediated transfection by inclusion of adenovirus in coprecipitates.Hepatocyte-targeted in vivo gene expression by intravenous injection of plasmid DNA complexed with synthetic multi-functional gene delivery system.Ligand-mediated retargeting of recombinant adenovirus for gene transfer in vivo.
P2860
Q28204373-D6EC6EC4-3E57-45FA-BF93-5528B49B448BQ31048758-DC1FF507-4BC7-4C7B-9AA1-08DE686BFE5EQ33718826-88812D9D-A808-48D7-83AB-5A3C853A46FCQ33818166-8EDB5A62-A2CB-45D9-906F-87F9CA70C03AQ34076933-A644C61E-AF6E-47D4-BE41-07F2AF9F5723Q34138051-A9151363-E736-4C53-A9C3-D9430B2845D8Q34202163-9F342E38-7257-4545-B541-3C3FAF02B522Q34325086-FA349CDE-363E-47A3-AF8C-1291720E8FAFQ34893888-5129AA00-9334-4760-8B6D-341B460A4657Q35144032-8794D004-410C-4536-A94D-BE7F2F698CA6Q35631781-72D45F0E-AF24-4CFF-B921-735B7FF6264FQ35652189-27EC3EA7-7B62-4BAE-BA72-159249612CD1Q35777606-2A8D9992-BF1F-4048-8A30-AD130DD77327Q35831992-249F0DCD-12D6-4BC8-A302-47394B088DBDQ35874408-B4FAD456-3FC6-4D44-AD0B-1B5E9F5597E7Q36481006-0F40631C-AF91-43B4-AF85-42E82637F56AQ36620168-BF12860C-7CBF-4FC8-8142-21A556EC5E8BQ36713121-E8547BAF-C187-4A82-9C4A-77732CEBCCEEQ36966120-7088BF97-D302-4416-B4C4-93A996822874Q37512409-460788A5-F30B-4DAD-9573-E737B804697DQ38358020-45853639-BD92-4538-8654-0C6EDB1B75AEQ38383086-B67678CC-04A4-4400-9E39-DFAE968DC41DQ40381389-9098595F-EE46-423B-AE60-BB7F23AB050EQ40409746-5510E2AB-4C09-4D6C-9903-581657C8AAFDQ41301412-9313CBEC-59B6-4995-B52D-374A831C3FC9Q41368217-F4850E4A-52BA-404E-BE55-A3583A7D4B0EQ41924509-BB8988AF-3BFE-4C70-8F79-A06610BA88F7Q42811203-2F9B72B0-6E92-4FEB-9675-D91DFA7AE9DDQ45867740-3CC2D2D5-34C1-4AA8-BC25-29DDB3FD9AD9Q45868921-CF526E16-3442-4A0B-AE1F-FF8C3114AFC6
P2860
Hepatic gene therapy: adenovirus enhancement of receptor-mediated gene delivery and expression in primary hepatocytes.
description
1993 nî lūn-bûn
@nan
1993年の論文
@ja
1993年論文
@yue
1993年論文
@zh-hant
1993年論文
@zh-hk
1993年論文
@zh-mo
1993年論文
@zh-tw
1993年论文
@wuu
1993年论文
@zh
1993年论文
@zh-cn
name
Hepatic gene therapy: adenovir ...... ession in primary hepatocytes.
@ast
Hepatic gene therapy: adenovir ...... ession in primary hepatocytes.
@en
type
label
Hepatic gene therapy: adenovir ...... ession in primary hepatocytes.
@ast
Hepatic gene therapy: adenovir ...... ession in primary hepatocytes.
@en
prefLabel
Hepatic gene therapy: adenovir ...... ession in primary hepatocytes.
@ast
Hepatic gene therapy: adenovir ...... ession in primary hepatocytes.
@en
P2093
P2860
P356
P1476
Hepatic gene therapy: adenovir ...... ession in primary hepatocytes.
@en
P2093
P2860
P304
P356
10.1073/PNAS.90.6.2122
P407
P577
1993-03-01T00:00:00Z